Abstract:Background: Oritavancin is a new generation of semi-synthetic glycopeptide antibiotics against Gram-positive bacteria, which served as the first and only antibiotic with a single-dose therapeutic regimen to treat ABSSSI. A naturally occurring glycopeptide A82846B is the direct precursor of oritavancin. However, its application has been hampered by low yields and homologous impurities. This study established a multi-step combinatorial strategy to rationally construct a high-quality and high-efficiency biosynthesis system for A82846B and systematically optimize its fermentation process to break through the bottleneck of microbial fermentation production. Results: Firstly, based on the genome sequencing and analysis, we deleted putative competitive pathways and constructed a better A82846B-producing strain with a cleaner metabolic background, increasing A82846B production from 92 to 174 mg/L. Subsequently, the PhiC31 integrase system was introduced based on the CRISPR-Cas12a system. Then, the fermentation level of A82846B was improved to 226 mg/L by over-expressing the pathway-specific regulator StrR via the constructed PhiC31 system. Furthermore, overexpressing glycosyl-synthesis gene evaE enhanced the production to 332 mg/L due to the great conversion of the intermediate to target product. Finally, the scale-up production of A82846B reached 725 mg/L in a 15 L fermenter under fermentation optimization, which is the highest reported yield of A82846B without the generation of homologous impurities. Conclusion: Under approaches including blocking competitive pathways, inserting site-specific recombination system, overexpressing regulator, overexpressing glycosyl-synthesis gene and optimizing fermentation process, a multi-step combinatorial strategy for the high-level production of A82846B was developed, constructing a high-producing strain AO-6. The combinatorial strategies employed here can be widely applied to improve the fermentation level of other microbial secondary metabolites, providing a reference for constructing an efficient microbial cell factory for high-value natural products.

Effective Utilization of Wastewater for Valuable Validamycin A Biosynthesis by Streptomyces Hygroscopicus K2509 in Plant-Scale Bioreactor

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Optimization of fermentation conditions for production of a novel antifungal metabolite by response surface methodology

Enhanced Production of Validamycin A in Streptomyces Hygroscopicus 5008 by Engineering Validamycin Biosynthetic Gene Cluster.

Production of Validamycin A from Hemicellulose Hydrolysate by Streptomyces Hygroscopicus 5008.

Simultaneous Removal and Evaluation of Organic Substrates and NH3-N by a Novel Combined Process in Treating Chemical Synthesis-Based Pharmaceutical Wastewater

Optimized submerged batch fermentation for metabolic switching in Streptomyces yanglinensis 3–10 providing platform for reveromycin A and B biosynthesis, engineering, and production

Study on production enhancement of validamycin A using online capacitance measurement coupled with 1H NMR spectroscopy analysis in a plant-scale bioreactor

Rational construction of a high-quality and high-efficiency biosynthetic system and fermentation optimization for A82846B based on combinatorial strategies in Amycolatopsis orientalis

Novel Spectrophotometric Approach for Determination of Validamycin A in Fermentation of Streptomyces Hygroscopicus

A novel of transforming wastewater pollution into resources for desertification control by sand-consolidating cyanobacteria, Scytonema javanicum

Sustainable Wastewater Treatment Via PV-distillation Hybrid Process for the Separation of Ethyl Acetate/isopropanol/water

Use of Filamentous Fungi for Wastewater Treatment and Production of High Value Fungal Byproducts: A Review

A study on the screening of fungal strains and the degradation of COD in vancomycin production wastewater

Enhancement of validamycin A production by addition of ethanol in fermentation of Streptomyces hygroscopicus 5008.

Whole Process Reclamation and Utilization of Wastes Produced in the Biological Fermentation Industry

Application of Bioaugmentation to Improve Pharmaceutical Wastewater Treatment Efficiency

Enhanced hydrolysis of fermentative antibiotics in production wastewater: Hydrolysis potential prediction and engineering application

Temperature Shift-Induced Reactive Oxygen Species Enhanced Validamycin A Production in Fermentation of Streptomyces Hygroscopicus 5008.

Genomic and Transcriptomic Insights into the Thermo-Regulated Biosynthesis of Validamycin in Streptomyces Hygroscopicus 5008

Engineering Validamycin Production by Tandem Deletion of Γ-Butyrolactone Receptor Genes in Streptomyces Hygroscopicus 5008